These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28055963)

  • 21. Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
    Holien T; Olsen OE; Misund K; Hella H; Waage A; Rø TB; Sundan A
    Eur J Haematol; 2013 Oct; 91(4):339-46. PubMed ID: 23869695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical pattern of c-MYC protein judged as "+/(weak)+/-" by a new notation correlates with MYC gene nontranslocation in large B-cell lymphoma.
    Fujishima F; Katsushima H; Fukuhara N; Konosu-Fukaya S; Nakamura Y; Usubuchi H; Sato S; Ota Y; Yashima-Abo A; Nakamura T; Nakaya N; Harigae H; Sasano H; Ichinohasama R
    Hum Pathol; 2019 Mar; 85():112-118. PubMed ID: 30448222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of t(8;14) c-myc/IgH gene rearrangement by long-distance polymerase chain reaction in patients with diffuse large B-cell lymphoma.
    Kiaei A; Onsori H; Alijani A; Andalib S; Ghorbian S; Sakhinia E
    Hematol Oncol Stem Cell Ther; 2016 Dec; 9(4):141-146. PubMed ID: 27352258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
    Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y
    Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
    Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
    Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
    Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
    Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab.
    Kobayashi T; Tsutsumi Y; Sakamoto N; Nagoshi H; Yamamoto-Sugitani M; Shimura Y; Mizutani S; Matsumoto Y; Nishida K; Horiike S; Asano N; Nakamura S; Kuroda J; Taniwaki M
    Jpn J Clin Oncol; 2012 Nov; 42(11):1035-42. PubMed ID: 22984125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
    Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
    Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
    Han Y; Park S; Kinyua AW; Andera L; Kim KW; Kim I
    Oncol Rep; 2014 Jan; 31(1):456-62. PubMed ID: 24213797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting positive cofactor 4 induces autophagic cell death in MYC-expressing diffuse large B-cell lymphoma.
    Ma L; Gong Q; Chen Y; Luo P; Chen J; Shi C
    Exp Hematol; 2023; 119-120():42-57.e4. PubMed ID: 36642374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase.
    Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B
    Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of BCL6, MYC, P53 genes abnormalities for the prognosis of diffuse large B-cell lymphoma].
    Gao P; Li Q; Wang Z; Yan F; Lu C; Cao X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):628-31. PubMed ID: 25297597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase.
    Zou D; Yi S; Cui R; Liu W; Li C; Zhong S; Yu Z; Li Z; Lv R; Ru K; Wang H; An G; Xu Y; Qiu L
    BMC Med Genet; 2017 Feb; 18(1):16. PubMed ID: 28209136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYC and aggressive B-cell lymphomas.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.
    Devlin JR; Hannan KM; Ng PY; Bywater MJ; Shortt J; Cullinane C; McArthur GA; Johnstone RW; Hannan RD; Pearson RB
    FEBS J; 2013 Nov; 280(21):5307-16. PubMed ID: 23331925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells.
    Möller M; Herzer K; Wenger T; Herr I; Wink M
    Oncol Rep; 2007 Sep; 18(3):737-44. PubMed ID: 17671728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.